Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ben-Baruch

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Gynecologic Oncology|September 28, 2000
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations statusA Fishman, E Dekel, A Chetrit, et al.
Harefuah|July 27, 2000
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]L Theodor, R Shiri-Sverdlov, G H Yechezkel, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in IsraelA Ravid, I Barshack, G Hirsh-Yechezkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Gynecologic Oncology|September 28, 2000
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations statusA Fishman, E Dekel, A Chetrit, et al.
Harefuah|July 27, 2000
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]L Theodor, R Shiri-Sverdlov, G H Yechezkel, et al.
JAMA|December 11, 1996
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerB Modan, E Gak, R B Sade-Bruchim, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in IsraelA Ravid, I Barshack, G Hirsh-Yechezkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
Pageof 12